Niacin Use and Cutaneous Flushing: Mechanisms and Strategies for Prevention

This publication has 29 references indexed in Scilit:

• Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients
  Current Medical Research and Opinion, 2007
• Safety Considerations with Niacin Therapy
  The American Journal of Cardiology, 2007
• Antagonism of the prostaglandin D ₂ receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans
  Proceedings of the National Academy of Sciences, 2006
• Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
  Journal of Internal Medicine, 2005
• Nicotinic Acid and Pyridoxine Modulate Arachidonic Acid Metabolism in vitro and ex vivo in Man
  Basic & Clinical Pharmacology & Toxicology, 1999
• Identification of Skin as a Major Site on Prostaglandin D2 Release Following Oral Administration of Niacin in Humans
  Journal of Investigative Dermatology, 1992
• Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
  JACC, 1986
• The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man
  Clinical Pharmacology & Therapeutics, 1969
• THE VASODILATING EFFECTS OF NICOTINIC ACID
  The American Journal of the Medical Sciences, 1943
• THE USE OF NICOTINIC ACID IN THE TREATMENT OF PELLAGRA
  JAMA, 1938